I agree that this site is using cookies. You can find further informations here.
X
Oura, Tomonori
55  results:
Search for persons X
?
1

Metabolic Abnormalities Following Tirzepatide Monotherapy i..:

Onishi, Yukiko ; Oura, Tomonori ; Takeuchi, Masakazu
Diabetes Therapy.  15 (2024)  3 - p. 649-661 , 2024
Link: https://doi.org/10.1007/..
 
?
2

Glycaemic control, body weight, and safety of tirzepatide v..:

Osonoi, Takeshi ; Oura, Tomonori ; Hirase, Tetsuaki
Diabetes, Obesity and Metabolism.  26 (2023)  1 - p. 126-134 , 2023
Link: https://doi.org/10.1111/..
 
?
3

Treatment Satisfaction and Quality of Life with Tirzepatide..:

Ishii, Hitoshi ; Oura, Tomonori ; Takeuchi, Masakazu
Diabetes Therapy.  14 (2023)  12 - p. 2173-2183 , 2023
Link: https://doi.org/10.1007/..
 
?
4

Change in pharmacodynamic variables following once‐weekly t..:

Yabe, Daisuke ; Kawamori, Dan ; Seino, Yusuke..
Diabetes, Obesity and Metabolism.  25 (2022)  2 - p. 398-406 , 2022
Link: https://doi.org/10.1111/..
 
?
5

A phase 1 multiple‐ascending dose study of tirzepatide in J..:

Furihata, Kenichi ; Mimura, Hanaka ; Urva, Shweta...
Diabetes, Obesity and Metabolism.  24 (2021)  2 - p. 239-246 , 2021
Link: https://doi.org/10.1111/..
 
?
6

Ultra‐Rapid Lispro results in accelerated insulin lispro ab..:

Shiramoto, Masanari ; Nasu, Risa ; Oura, Tomonori..
Journal of Diabetes Investigation.  11 (2020)  3 - p. 672-680 , 2020
Link: https://doi.org/10.1111/..
 
?
7

Efficacy and safety of subgroup analysis stratified by base..:

Kaneko, Shizuka ; Oura, Tomonori ; Matsui, Akiko..
Endocrine Journal.  64 (2017)  12 - p. 1165-1172 , 2017
Link: https://doi.org/10.1507/..
 
?
8

Evaluation of the impact of once weekly dulaglutide on pati..:

Suzuki, Shuichi ; Oura, Tomonori ; Takeuchi, Masakazu.
Health and Quality of Life Outcomes.  15 (2017)  1 - p. , 2017
Link: https://doi.org/10.1186/..
 
?
9

Pancreatic safety in Japanese patients with type 2 diabetes..:

Emoto, Masanori ; Oura, Tomonori ; Matsui, Akiko..
Endocrine Journal.  64 (2017)  2 - p. 191-206 , 2017
Link: https://doi.org/10.1507/..
 
?
10

Analysis of efficacy and safety of dulaglutide 0.75 mg stra..:

Onishi, Yukiko ; Oura, Tomonori ; Matsui, Akiko..
Endocrine Journal.  64 (2017)  5 - p. 553-560 , 2017
Link: https://doi.org/10.1507/..
 
?
11

The combination of dulaglutide and biguanide reduced bodywe..:

Inagaki, Nobuya ; Araki, Eiichi ; Oura, Tomonori...
Diabetes, Obesity and Metabolism.  18 (2016)  12 - p. 1279-1282 , 2016
Link: https://doi.org/10.1111/..
 
?
12

Subgroup analysis of phase 3 studies of dulaglutide in Japa..:

Onishi, Yukiko ; Oura, Tomonori ; Nishiyama, Hiroshi...
Endocrine Journal.  63 (2016)  3 - p. 263-273 , 2016
Link: https://doi.org/10.1507/..
 
?
13

A 1-year safety study of dulaglutide in Japanese patients w..:

Emoto, Masanori ; Terauchi, Yasuo ; Ozeki, Akichika...
Endocrine Journal.  62 (2015)  12 - p. 1101-1114 , 2015
Link: https://doi.org/10.1507/..
 
?
14

Cancer Outlier Analysis Based on Mixture Modeling of Gene E..:

Mori, Keita ; Oura, Tomonori ; Noma, Hisashi.
Computational and Mathematical Methods in Medicine.  2013 (2013)  - p. 1-8 , 2013
Link: https://doi.org/10.1155/..
 
?
15

Efficacy and Safety Profile of Exenatide Once Weekly Compar..:

Inagaki, Nobuya ; Atsumi, Yoshihito ; Oura, Tomonori..
Clinical Therapeutics.  34 (2012)  9 - p. 1892-1908.e1 , 2012
Link: https://doi.org/10.1016/..
 
1-15